Data Management and Biometrics at Celerion bridges the gap between medical practice and laboratory science by assessing the safety of drug products to maximize drug effects and minimize side effects.
The scientists at Celerion design efficient, scientifically sound clinical studies; analyze and interpret data from these studies; and use the knowledge obtained to design the next study in the drug-development cycle. The scientists provide the following:
- Estimate optimal dosing for human studies based on animal or human results
- Design early clinical research studies and write protocols to evaluate safety and PK/PD
- Analyze and interpret data from clinical studies
- Communicate results from human studies for regulatory filings
Celerion has one of the most experienced Data Management and Biometrics teams in the industry, with over 120 staff operating across five global locations in Europe and North America and nearly 40 years of experience. A dedicated European team offers the full range of Celerion’s data management and biometric services to European* clients, and with scientists located in Belfast and Zürich, allows clients to consult and interact with study design experts, clinical pharmacologists, data programmers and biostatisticians in EU time-zone. Global SOPs and harmonised data flow processes provide clients with the opportunity of sharing their clinical and bioanalytical work globally across Celerion’s North American and European sites, while working consistently with the same European Data Management and Biometrics team.
*Not just European – also middle east/Israeli/Asian clients